First-in-human phase I study of immunomodulatory E7046, an antagonist of PGE2-receptor E-type 4 (EP4), in patients with advanced cancers
暂无分享，去创建一个
G. Shapiro | F. Meric-Bernstam | A. Naing | D. Hong | Amy Y Siu | A. Marabelle | M. Ren | A. Parikh | A. Varga | I. Tchakov | C. E. Ooi | L. Reyderman | Xingfeng Bao | T. Binder | P. Sachdev | Ö. Ataman | Mingjie Liu | V. Bhagawati-Prasad | Satish Dayal | Lucy Xu